MoReLife - real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients.
Annals of hematology
View this publicationAnnals of hematology
View this publicationJournal of immunology (Baltimore, Md. : 1950)
View this publicationPublication categories: Top publication
Proceedings of Machine Learning Research
View this publicationAlzheimer's & dementia : the journal of the Alzheimer's Association
View this publicationInternational journal of molecular sciences
View this publicationInternational journal of molecular sciences
View this publicationScience immunology
View this publicationThe Lancet. Neurology
View this publicationJACC. Cardiovascular interventions
View this publicationbioRxiv : the preprint server for biology
View this publication